Matrix Capital Management Company’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $21.1M | Hold |
|
|||||
|
2025
Q2 | $16.2M | Hold |
|
|||||
|
2025
Q1 | $22.2M | Hold |
|
|||||
|
2024
Q4 | $42.3M | Hold |
|
|||||
|
2024
Q3 | $51.4M | Hold |
|
|||||
|
2024
Q2 | $57.1M | Hold |
|
|||||
|
2024
Q1 | $220M | Hold |
|
|||||
|
2023
Q4 | $211M | Hold |
|
|||||
|
2023
Q3 | $280M | Hold |
|
|||||
|
2023
Q2 | $394M | Buy |
|
|||||
|
2023
Q1 | $158M | Hold |
|
|||||
|
2022
Q4 | $185M | Hold |
|
|||||
|
2022
Q3 | $199M | Hold |
|
|||||
|
2022
Q2 | $259M | Buy |
|
|||||
|
2022
Q1 | $201M | Hold |
|
|||||
|
2021
Q4 | $366M | Hold |
|
|||||
|
2021
Q3 | $290M | Buy |
|
|||||
|
2021
Q2 | $218M | Buy |
|
|||||
|
2021
Q1 | $166M | Hold |
|
|||||
|
2020
Q4 | $199M | Hold |
|
|||||
|
2020
Q3 | $125M | Hold |
|
|||||
|
2020
Q2 | $184M | Buy |
|